Showing results (611-620 of 632) with videos related to

Sort By:
Pageof 64
European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
JCO Precision Oncology|July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision OncologySophia C Kamran, Monica Borges, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate CancerWilliam A Hall, Eric Paulson, Brian J Davis, et al.
Journal of Oncology Practice|August 15, 2013
Practice-based evidence to evidence-based practice: building the National Radiation Oncology RegistryJason A Efstathiou, Deborah S Nassif, Todd R McNutt, et al.
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.
JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Nano Today|January 30, 2023
Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAsJasmine J Wang, Na Sun, Yi-Te Lee, et al.
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
Pageof 64